Editorial: Preventative nutritional approaches against inflammatory diseases
Frontiers in Nutrition · 19.11.2026 · 13
DOI: 10.3389/fnut.2026.2052354 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Nutrition, online erschienen am 19.11.2026. Verfasst von Zhenhuan Zhao und 1 weiteren Autor:innen. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic, low-grade inflammation is a shared biological thread running through rheumatic and musculoskeletal diseases, metabolic disorders, cardiovascular disease, and neurodegenerative diseases, and it is a common pathway linking ageing, lifestyle exposures, and disease risk (Furman et al., 2019). It is also increasingly understood as modifiable. Diet acts on systemic inflammation through adiposity, mucosal immunity, gut microbial ecology, and cardiometabolic health: Western dietary patterns engage innate and adaptive immune circuits (Christ et al., 2019), and higher ultraprocessed food consumption is associated with excess all-cause and cause-specific mortality in large prospective cohorts (Fang et al., 2024). These pathways make nutritional strategies attractive for prevention rather than symptom management. Yet dietary guidelines for preventing inflammatory disease remain poorly defined, because the evidence behind them is fragmented.Single-nutrient studies yield inconsistent results, dietary-pattern studies are largely observational, and most data derive from patients with established disease or from animal models of uncertain translational relevance. Few interventions are stratified by immunological or genetic profile.Against this background, this Research Topic "Preventative Nutritional Approaches Against Inflammatory Diseases" brings six contributions to address these gaps. We solicited studies of paediatric rheumatology, immunogenetics, supplementation trials, functional foods, and prognostic biomarkers. Collectively, they illustrate both the promise and the methodological limits of preventative nutritional immunology.Who should receive preventive nutritional advice? White et al. add an immunogenetic dimension.In a retrospective real-world cohort of individuals with self-reported wheat/gluten sensitivity, they observed a 100% cumulative frequency of HLA-DQ susceptibility variants [DQ1 (56%), DQ2 (54%), DQ3 (40%), and DQ8 (33%)], and 68% exhibited specific IgG reactivity. The findings support stratification by HLA-DQ and serological profiles rather than treating self-reported gluten sensitivity as a single entity. However, the cohort was small, convenience-sampled, and selfreported, and HLA-DQ variants are common in the general population; clinical value will depend on prospective validation and on predicting responses to specific interventions. Karadimova-Watts et al. ask whether nutrition can prevent rheumatoid arthritis (RA), a disease with a prolonged preclinical phase in which genetic susceptibility and modifiable exposures interact. They synthesize evidence that nutrition may modify RA risk through adiposity, systemic inflammation, mucosal immunity, the gut microbiome, and cardiometabolic comorbidity. Their most important message is conceptual: if diet acts before clinical onset, the target of prevention is not the inflamed joint but the immunological trajectory preceding it. This argues for prospective cohorts capturing diet, immune markers, and disease onset rather than cross-sectional associations.Which interventions are sufficiently supported? Boyarchuk and Kovalchuk examine zinc in juvenile idiopathic arthritis (JIA), where chronic inflammation, reduced intake, and treatment may compromise nutritional status. Children with JIA had lower dietary zinc intake than controls (median 5.85 vs. 7.59 mg/day), and 96.4% fell below age-and sex-specific recommended intake versus 62.1% of controls. Low serum zinc was more frequent in JIA (29.8% vs. 14.5%), though not conventionally significant, and was associated with higher erythrocyte sedimentation rate, patient and physician global assessments, and JADAS-27 scores. The study does not establish that supplementation improves disease activity, but identifies a plausible, easily screenable nutritional gap in paediatric rheumatology, where growth, appetite, and bone health are already at stake. Kumar et al. take a different approach, testing a polyherbal and probiotic immunostimulatory formulation for gut dysbiosis in colorectal cancer. Using computational docking, cell-line assays, and a mouse model, they identify formulation F3B as most active and report modulation of apoptotic, oncogenic, and immunomodulatory markers alongside microbial ecological change.The work connects two themes: the microbiome as a nutritional target and multi-component formulations for complex ecological dysfunction. Yet the evidence is early-stage; small animal groups, a single tumour model, and botanical variability limit generalization. Standardization, safety assessment, and randomized clinical evaluation are essential before preventive claims can be made.How should nutritional risk be measured? Li et al. examine albumin-related inflammatory ratios in rheumatic heart disease (RHD). In a dual-cohort study of 496 patients from MIMIC-IV and 268 from a Chinese hospital, the red cell distribution width-to-albumin ratio (RAR) was the strongest and most consistent predictor of 30-day mortality (adjusted hazard ratios 4.12 and 3.20), providing incremental value beyond established severity scores. This is not an intervention study, but it makes an important point: nutritional status is not a passive accompaniment of chronic inflammation but a measurable prognostic modifier. Simple, low-cost indices may identify patients who would benefit most from nutritional assessment, particularly in resource-limited settings where RHD burden is highest. The systematic review by Camargo et al. is a useful corrective to enthusiasm for single supplements. Across eight randomized double-blind placebo-controlled trials, creatine did not significantly reduce C-reactive protein, interleukin-6, or other inflammatory biomarkers; certainty of evidence was moderate. The null result is informative: creatine's ergogenic role should not be conflated with immunomodulation, and future trials must account for baseline inflammation, exercise context, dose, duration, and tissue-specific outcomes.Several cross-cutting priorities emerge. First, the field must move from single nutrients to dietary patterns and from average to stratified effects, using immunogenetic, microbiome, and inflammatory profiles to identify responders. Second, trials should adopt standardized, clinically meaningful endpoints rather than isolated biomarker changes. Third, mechanistic work must connect dietary exposures to immune cell function, barrier integrity, and microbial metabolism.Fourth, implementation research is needed to translate evidence into acceptable, affordable, and sustainable advice. Prevention is not a single nutrient, supplement, or dietary label. It is a lifecourse strategy integrating food quality, metabolic health, immune regulation, and the social conditions shaping what people eat. The contributions here map parts of that strategy, from preclinical autoimmunity to prognostic assessment, and clarify where evidence is strong, promising, or still thin. The next step is collaborative, stratified, clinically anchored research.
Zitieren
APA
Zhao, Z., & Wang, S. (2026). Editorial: Preventative nutritional approaches against inflammatory diseases. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.2052354
Vancouver
Zhao Z, Wang S. Editorial: Preventative nutritional approaches against inflammatory diseases. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.2052354
BibTeX
@article{Zhao2026,
author = {Zhao, Zhenhuan and Wang, Shao-bin},
title = {Editorial: Preventative nutritional approaches against inflammatory diseases},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.2052354}
}
EUVIMED